This inventor holds 1 USPTO granted patent. Top assignee: S O 'Pharmachim'. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: The Innovative Contributions of Ani I Genova
Introduction
Ani I Genova is a notable inventor based in Sofia, Bulgaria. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative antihypoxic drug. His work focuses on developing treatments that enhance the body's resilience against hypoxic conditions.
Latest Patents
Ani I Genova holds a patent for an antihypoxic drug and method of its application. This drug, which combines piracetam and orotic acid or their pharmaceutically tolerable salts, is designed to provide both verebroprotective and hepatoprotective effects. The formulation is administered in varying daily doses, ranging from 0.150 to 50 g for acute conditions and from 0.030 to 0.30 g for chronic diseases. The synergistic effect of this combination has been confirmed by clinical data, demonstrating its efficacy in treating both acute and chronic diseases as well as exogenic intoxications. The drug can be administered orally or parenterally, making it versatile for different medical scenarios.
Career Highlights
Ani I Genova is associated with S O Pharmachim, where he continues to develop and refine his innovative pharmaceutical solutions. His dedication to research and development has positioned him as a key figure in the field of drug formulation.
Collaborations
Ani collaborates with several professionals in his field, including Milka P Nikolova and Maria G Todorova. These collaborations enhance the research and development process, allowing for a more comprehensive approach to innovation in pharmaceuticals.
Conclusion
Ani I Genova's contributions to the field of pharmaceuticals, particularly through his antihypoxic drug, highlight his innovative spirit and commitment to improving medical treatments. His work continues to impact the lives of those suffering from hypoxic conditions and exogenic intoxications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile